Company / Return on Assets (ROA)
BioLife Solutions, Inc. Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-1.1%
FY2025
5-year range
-31.1% / -1.1%
FY2021-FY2025
Trend
+77.6%
vs FY2024
Sector context
#98 of 158
Health Care
What the data says
At -1.1%, BioLife Solutions, Inc.'s return on assets (roa) ranks #98 of 158 in the Health Care sector. Return on Assets (ROA) has increased for 3 consecutive years, from -31.1% in FY2022 to -1.1% in FY2025.
Based on SEC 10-K filings.
-1.1% in FY2025 with a 5-year CAGR of -2.0%.
Improved from -16.5% to -1.1% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +29.9pp
- 5-Year Change
- -2.0pp
- 10-Year Change
- -
Sector benchmark
#98 of 158 in Health CareTop 62% of 158This company -1.1% Sector average -2.2%
▼
+48.5% above sector average
Key checks
Key Insights
- BioLife Solutions, Inc.'s return on assets (roa) has grown for 3 consecutive years.
- In FY2025, return on assets (roa) increased 77.6% year-over-year.
- Currently 1.1pp above the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score 4.67 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -1.1% | +77.6% |
| FY2024 | -5.1% | +69.4% |
| FY2023 | -16.5% | +46.9% |
| FY2022 | -31.1% | -1828.6% |
| FY2021 | -1.6% | -291.7% |
| FY2020 | 0.8% | +146.9% |
| FY2019 | -1.8% | -104.5% |
| FY2018 | 39.6% | +291.4% |
| FY2017 | -20.7% | +76.1% |
| FY2016 | -86.7% | -154.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026